Mapp Biopharmaceutical

Shares of Ibio Inc (NYSE: IBIO) continued higher Tuesday following the 60 Minutes broadcast about ZMapp on CBS by the late Bob Simon. Between February 12 and February 17, the stock rose approximately 125 percent amid news that the company’s plant-based antibody manufacturing technology...